Conversion Surgery for Pancreatic Cancer—The Impact of Neoadjuvant Treatment

Volume: 9
Published: Jan 14, 2020
Abstract
Pancreatic ductal adenocarcinoma (PDAC) still has a dismal prognosis, mainly because only 15-20% of all patients present with resectable tumors at the time of diagnosis. Upfront resection is not reasonable in the majority of patients due to locally extended tumor growth or distant metastases. PDAC will become the second most frequent cause of cancer-related death for both men and women within the next 10 years. While there is currently no...
Paper Details
Title
Conversion Surgery for Pancreatic Cancer—The Impact of Neoadjuvant Treatment
Published Date
Jan 14, 2020
Volume
9
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.